194 related articles for article (PubMed ID: 35011816)
1. Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure.
Yalçin F; Yalçin H; Küçükler N; Arslan S; Akkuş O; Kurtul A; Abraham MR
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011816
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic stress and microscopic remodeling.
Yalçin F; Yalçin H; Abraham R; Abraham TP
Int J Cardiol Cardiovasc Risk Prev; 2021 Dec; 11():200115. PubMed ID: 34806089
[TBL] [Abstract][Full Text] [Related]
3. Stress and Heart in Remodeling Process: Multiple Stressors at the Same Time Kill.
Yalçin F; Abraham MR; Garcia MJ
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731125
[TBL] [Abstract][Full Text] [Related]
4. Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging.
Yalçin F; Yalçin H; Abraham MR; Abraham TP
Am J Cardiovasc Dis; 2021; 11(5):628-634. PubMed ID: 34849295
[TBL] [Abstract][Full Text] [Related]
5. Specific deformation pattern in hypertensive patients with septal bulge and preserved systolic function.
Separovic Hanzevacki J; Reskovic Luksic V
Int J Cardiovasc Imaging; 2022 Nov; 38(11):2323-2331. PubMed ID: 36434339
[TBL] [Abstract][Full Text] [Related]
6. Association between basal septal hypertrophy and left ventricular geometry in a community population.
Gao L; Ma W; Li M; Yang Y; Qi L; Zhang B; Wang C; Zhang Y; Huo Y
BMC Cardiovasc Disord; 2022 Dec; 22(1):579. PubMed ID: 36587201
[TBL] [Abstract][Full Text] [Related]
7. Basal Ventricular Septal Hypertrophy in Systemic Hypertension.
Loncaric F; Nunno L; Mimbrero M; Marciniak M; Fernandes JF; Tirapu L; Fabijanovic D; Sanchis L; Doltra A; Cikes M; Lamata P; Bijnens B; Sitges M
Am J Cardiol; 2020 May; 125(9):1339-1346. PubMed ID: 32164912
[TBL] [Abstract][Full Text] [Related]
8. The effect of dobutamine stress on left ventricular outflow tract gradients in hypertensive patients with basal septal hypertrophy.
Yalçin F; Muderrisoglu H; Korkmaz ME; Ozin B; Baltali M; Yigit F
Angiology; 2004; 55(3):295-301. PubMed ID: 15156263
[TBL] [Abstract][Full Text] [Related]
9. Myocardial remodeling in hypertension.
Nadruz W
J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
[TBL] [Abstract][Full Text] [Related]
10. Distribution of myocardial work in arterial hypertension: insights from non-invasive left ventricular pressure-strain relations.
Loncaric F; Marciniak M; Nunno L; Mimbrero M; Fernandes JF; Fabijanovic D; Sanchis L; Doltra A; Montserrat S; Cikes M; Lamata P; Bijnens B; Sitges M
Int J Cardiovasc Imaging; 2021 Jan; 37(1):145-154. PubMed ID: 32789553
[TBL] [Abstract][Full Text] [Related]
11. Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy.
Yalçin F; Kucukler N; Cingolani O; Mbiyangandu B; Sorensen L; Pinherio A; Abraham MR; Abraham TP
J Appl Physiol (1985); 2019 Feb; 126(2):354-362. PubMed ID: 29357486
[TBL] [Abstract][Full Text] [Related]
12. Correlation between systolic deformation and dyssynchrony indices and the grade of left ventricular hypertrophy in hypertensive patients with a preserved systolic ejection fraction undergoing coronary angiography, based on tissue Doppler imaging.
Zoroufian A; Razmi T; Savandroomi Z; Tokaldany ML; Sadeghian H; Sahebjam M; Jalali A
J Ultrasound Med; 2014 Jan; 33(1):119-28. PubMed ID: 24371106
[TBL] [Abstract][Full Text] [Related]
13. Could early septal involvement in the remodeling process be related to the advance hypertensive heart disease?
Yalçin F; Topaloglu C; Kuçukler N; Ofgeli M; Abraham TP
Int J Cardiol Heart Vasc; 2015 Jun; 7():141-145. PubMed ID: 28785662
[TBL] [Abstract][Full Text] [Related]
14. Septal curvature as a robust and reproducible marker for basal septal hypertrophy.
Marciniak M; Gilbert A; Loncaric F; Fernandes JF; Bijnens B; Sitges M; King A; Crispi F; Lamata P
J Hypertens; 2021 Jul; 39(7):1421-1428. PubMed ID: 33534345
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
16. Basal septal hypertrophy.
Kelshiker MA; Mayet J; Unsworth B; Okonko DO
Curr Cardiol Rev; 2013 Nov; 9(4):325-30. PubMed ID: 24313643
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
Sakata Y; Masuyama T; Yamamoto K; Nishikawa N; Yamamoto H; Kondo H; Ono K; Otsu K; Kuzuya T; Miwa T; Takeda H; Miyamoto E; Hori M
Circulation; 2000 Oct; 102(18):2269-75. PubMed ID: 11056104
[TBL] [Abstract][Full Text] [Related]
18. Relation of the left ventricular geometric patten to coronary artery disease in hypertensive patients using a 320-detector-row CT scanner.
Ismail ASM; Aouf MA; Diab RH; Baghdady YK
Egypt Heart J; 2023 Apr; 75(1):34. PubMed ID: 37186223
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.
Schimmel K; Ichimura K; Reddy S; Haddad F; Spiekerkoetter E
Front Cardiovasc Med; 2022; 9():886553. PubMed ID: 35600469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
